Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
iNtRON Bio, Demonstrated Toxin-Neutralizing Effect of IMPA™ Phage Engineering Technology in Colorectal Cancer Model and Completed the US Patent Application 2025-08-05 20:00
Ascletis Completes Enrollment in U.S. Phase IIa Study for Its Small Molecule Oral GLP-1R Agonist, ASC30, in Participants with Obesity or Overweight 2025-08-05 18:50
Fapon Biopharma Announces the enrollment of the First Patient in the Phase I Clinical Trial of FP008, A First-in-Class Immunotherapy for Solid Tumors 2025-08-05 16:30
WuXi XDC Achieves GMP Release of Newly Launched DP3 Facility at Wuxi Site, Scaling Further Drug Product Manufacturing Capacity 2025-08-05 10:13
Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032 2025-08-05 08:00
Raytone Biotech Announces First Patient Dosed in Clinical Trial of RTP-008 for Dry Eye Disease 2025-08-04 14:29
Mabwell Announces IND Application Acceptance for CDH17-Targeting ADC 7MW4911 from Both NMPA and FDA 2025-08-01 22:00
Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market 2025-08-01 20:00
Energenesis Biomedical Announces Positive Phase I Results for ENERGI-F705PD, a Potential Disease-Modifying Treatment for Parkinson's Disease 2025-08-01 15:52
GenScript Biotech's MSCI ESG Rating Upgraded to AA, Recognized as a Global Leader 2025-08-01 10:02
Chipscreen Biosciences' Brain-Penetrant Aurora B Selective Inhibitor CS231295 Tablet Receives FDA IND Approval, Advancing Global Clinical Development 2025-07-31 17:55
Akeso Announces Completion of First Dosing in Phase III Clinical Trial of Ivonescimab (PD-1/VEGF) Combination Therapy for Immunotherapy-Resistant NSCLC 2025-07-31 09:46
OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure 2025-07-31 04:10
BON Launches AI-Powered New Drug Research and Development 2025-07-30 21:00
Harbour BioMed to Present Phase II Data of HBM4003 and Tislelizumab Combination in MSS Metastatic Colorectal Cancer at ESMO 2025 2025-07-30 08:01
XellSmart Completed World's First Patient Dosing in its Registrational Clinical trial for iPSC-derived Subtype-specific Neural Cell Therapy for Spinal Cord Injury 2025-07-28 21:10
World's First Engineered Exosome for Hair Growth & Localized Fat Reduction Secure INCI Designation: ImmVira Accelerates Access to Billion-Dollar Aging-related Market 2025-07-28 20:28
Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results 2025-07-28 08:11
Angel Yeast Showcases Innovative Yeast Protein at 2025 IFT FIRST in Chicago 2025-07-24 21:00
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology 2025-07-24 19:30
1 13 14 15 16 17 262